Pub Date : 2026-01-30DOI: 10.1097/ju.0000000000004967
Daniel A Wollin,Michael E Lipkin,Glenn M Preminger
{"title":"Highlighting the 2025 AUA Nephrolithiasis Guidelines.","authors":"Daniel A Wollin,Michael E Lipkin,Glenn M Preminger","doi":"10.1097/ju.0000000000004967","DOIUrl":"https://doi.org/10.1097/ju.0000000000004967","url":null,"abstract":"","PeriodicalId":501636,"journal":{"name":"The Journal of Urology","volume":"93 1","pages":"101097JU0000000000004967"},"PeriodicalIF":0.0,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146089101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-30DOI: 10.1097/ju.0000000000004960
Alon Lazarovich,David J Nusbaum,Piyush K Agarwal,Parth K Modi
{"title":"Clinical trial design for BCG-unresponsive NMIBC - single-arm design was necessary, randomized trials are now essential.","authors":"Alon Lazarovich,David J Nusbaum,Piyush K Agarwal,Parth K Modi","doi":"10.1097/ju.0000000000004960","DOIUrl":"https://doi.org/10.1097/ju.0000000000004960","url":null,"abstract":"","PeriodicalId":501636,"journal":{"name":"The Journal of Urology","volume":"31 1","pages":"101097JU0000000000004960"},"PeriodicalIF":0.0,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146089102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-30DOI: 10.1097/ju.0000000000004966
Adree Khondker,Mandy Rickard,Samer Maher,Michael Chua,Rodrigo Romao,Joana Dos Santos,Armando J Lorenzo
OBJECTIVEPediatric hydronephrosis is associated with an increased risk of urinary tract infections (UTIs). Clinical guidelines recommend continuous antibiotic prophylaxis (CAP) for high-risk patients. In this study, we evaluated the association between hydroureteronephrosis and UTIs in infants.METHODSWe performed a single-center retrospective risk analysis of patients with prenatal hydronephrosis from 2015 to 2024, including those with isolated hydronephrosis and megaureter. Demographic and imaging characteristics, including anteroposterior diameter (APD), Society for Fetal Urology (SFU) grade, and maximum ureter diameter on first postnatal ultrasound, were recorded. The primary outcome was time to UTI development. Landmark analysis and competing risk analysis with cause-specific cox regression was employed to identify hazard ratios (HRs). Model performance was determined by concordance index.RESULTSAmong 803 patients (median follow-up 23 months) included in landmark analysis, 29 developed a UTI. On initial ultrasound, 124 patients had hydroureteronephrosis and 451 patients had high-grade hydronephrosis. On cause-specific Cox regression, UTI was associated with sex, uncircumcised status, hydroureter (HR 1.15 per mm, 95% CI 1.10, 1.21, p<0.001), while hydronephrosis alone, by SFU grade or APD, was not significantly associated. Model performance showed concordance index 0.74 (optimism-adjusted 0.72).CONCLUSIONThe presence of a hydroureter on initial postnatal ultrasound is a significant risk factor for UTI in infants with prenatal hydronephrosis, which supports the value of CAP in this subgroup. In contrast, isolated hydronephrosis does not appear to justify the use of prophylaxis.
目的：儿童肾积水与尿路感染（uti）风险增加相关。临床指南推荐高危患者持续抗生素预防（CAP）。在这项研究中，我们评估了婴儿输尿管积水与尿路感染之间的关系。方法对2015年至2024年产前肾积水患者进行单中心回顾性风险分析，包括孤立性肾积水和肾积水患者。记录人口统计学和影像学特征，包括前后径（APD）、胎儿泌尿学学会（SFU）分级和产后首次超声检查的最大输尿管直径。主要结果是尿路感染发展的时间。采用里程碑分析和竞争风险分析，并结合原因特异性cox回归确定风险比（hr）。通过一致性指数来确定模型的性能。结果纳入里程碑分析的803例患者（中位随访23个月）中，29例发生尿路感染。初步超声检查，124例患者为输尿管积水，451例患者为重度肾积水。在病因特异性Cox回归中，尿路感染与性别、未割包皮状况、输尿管积水相关（风险比1.15 / mm, 95% CI 1.10, 1.21, p<0.001），而单独的肾积水（SFU分级或APD）无显著相关。模型性能的一致性指数为0.74（乐观调整后为0.72）。结论产前肾积水患儿产前超声检查中输尿管的存在是尿路感染的重要危险因素，支持CAP在该亚组中的应用价值。相反，孤立性肾积水似乎不能证明使用预防措施是合理的。
{"title":"Ureteral dilation is a clinically significant risk factor for urinary tract infections in children with prenatal hydronephrosis: a call to revisit practice guidelines.","authors":"Adree Khondker,Mandy Rickard,Samer Maher,Michael Chua,Rodrigo Romao,Joana Dos Santos,Armando J Lorenzo","doi":"10.1097/ju.0000000000004966","DOIUrl":"https://doi.org/10.1097/ju.0000000000004966","url":null,"abstract":"OBJECTIVEPediatric hydronephrosis is associated with an increased risk of urinary tract infections (UTIs). Clinical guidelines recommend continuous antibiotic prophylaxis (CAP) for high-risk patients. In this study, we evaluated the association between hydroureteronephrosis and UTIs in infants.METHODSWe performed a single-center retrospective risk analysis of patients with prenatal hydronephrosis from 2015 to 2024, including those with isolated hydronephrosis and megaureter. Demographic and imaging characteristics, including anteroposterior diameter (APD), Society for Fetal Urology (SFU) grade, and maximum ureter diameter on first postnatal ultrasound, were recorded. The primary outcome was time to UTI development. Landmark analysis and competing risk analysis with cause-specific cox regression was employed to identify hazard ratios (HRs). Model performance was determined by concordance index.RESULTSAmong 803 patients (median follow-up 23 months) included in landmark analysis, 29 developed a UTI. On initial ultrasound, 124 patients had hydroureteronephrosis and 451 patients had high-grade hydronephrosis. On cause-specific Cox regression, UTI was associated with sex, uncircumcised status, hydroureter (HR 1.15 per mm, 95% CI 1.10, 1.21, p<0.001), while hydronephrosis alone, by SFU grade or APD, was not significantly associated. Model performance showed concordance index 0.74 (optimism-adjusted 0.72).CONCLUSIONThe presence of a hydroureter on initial postnatal ultrasound is a significant risk factor for UTI in infants with prenatal hydronephrosis, which supports the value of CAP in this subgroup. In contrast, isolated hydronephrosis does not appear to justify the use of prophylaxis.","PeriodicalId":501636,"journal":{"name":"The Journal of Urology","volume":"18 1 1","pages":"101097JU0000000000004966"},"PeriodicalIF":0.0,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146089100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-21DOI: 10.1097/ju.0000000000004945
Pierre Mozer,Aurelien Beaugerie,Marie-Aimée Perrouin-Verbe,Anne Denormandie,Juliette Cotte,Caroline Plassais,Stéphanie Tran,Dan Elliott,Emmanuel Chartier-Kastler
PURPOSETo evaluate the feasibility, safety, and efficacy during the first year of use of the UroActive® device in males with stress urinary incontinence (SUI).MATERIALS AND METHODSThis prospective, multicenter, single-arm, first-in-human study enrolled six male patients with bothersome SUI unresponsive to conservative or surgical treatments. After UroActive® implantation, follow up was planned for 5 years (post-activation). Study endpoints included successful device activation, revision, and explantation rates. Other endpoints assessed 24 h pad-weight test reduction, pad usage, uroflowmetry, post-void residual urine, patient-reported outcomes (ICIQ-UI SF, EQ-5D, I-QOL, USP). Adverse events were collected throughout the study.RESULTSAll six patients underwent successful implantation and device activation (100%). No explants or revisions were required during the 365 days post-activation. At 365 days post-activation, the pad weight was reduced by ≥50% in all patients and reduced by ≥75% in five (83.3%). Median pad use decreased from 3.7 to 1.0 pads/day. Uroflowmetry remained within acceptable ranges, and post-void residual urine was minimal. Quality of life scores significantly improved across all instruments. Nine device deficiencies were reported, all involving the patient remote control. No unanticipated serious adverse events occurred.CONCLUSIONSIn men with SUI, the UroActive® device demonstrates promising feasibility, safety, and functional outcomes during the 365 days post-activation. Patients experienced substantial symptom improvement and high satisfaction, with no surgical revisions. Larger studies with extended follow-up are needed to confirm these findings and assess long-term device performance.
{"title":"First-in human assessment of the UroActive® electronic Artificial Urinary Sphincter for treating male stress urinary incontinence (SUI).","authors":"Pierre Mozer,Aurelien Beaugerie,Marie-Aimée Perrouin-Verbe,Anne Denormandie,Juliette Cotte,Caroline Plassais,Stéphanie Tran,Dan Elliott,Emmanuel Chartier-Kastler","doi":"10.1097/ju.0000000000004945","DOIUrl":"https://doi.org/10.1097/ju.0000000000004945","url":null,"abstract":"PURPOSETo evaluate the feasibility, safety, and efficacy during the first year of use of the UroActive® device in males with stress urinary incontinence (SUI).MATERIALS AND METHODSThis prospective, multicenter, single-arm, first-in-human study enrolled six male patients with bothersome SUI unresponsive to conservative or surgical treatments. After UroActive® implantation, follow up was planned for 5 years (post-activation). Study endpoints included successful device activation, revision, and explantation rates. Other endpoints assessed 24 h pad-weight test reduction, pad usage, uroflowmetry, post-void residual urine, patient-reported outcomes (ICIQ-UI SF, EQ-5D, I-QOL, USP). Adverse events were collected throughout the study.RESULTSAll six patients underwent successful implantation and device activation (100%). No explants or revisions were required during the 365 days post-activation. At 365 days post-activation, the pad weight was reduced by ≥50% in all patients and reduced by ≥75% in five (83.3%). Median pad use decreased from 3.7 to 1.0 pads/day. Uroflowmetry remained within acceptable ranges, and post-void residual urine was minimal. Quality of life scores significantly improved across all instruments. Nine device deficiencies were reported, all involving the patient remote control. No unanticipated serious adverse events occurred.CONCLUSIONSIn men with SUI, the UroActive® device demonstrates promising feasibility, safety, and functional outcomes during the 365 days post-activation. Patients experienced substantial symptom improvement and high satisfaction, with no surgical revisions. Larger studies with extended follow-up are needed to confirm these findings and assess long-term device performance.","PeriodicalId":501636,"journal":{"name":"The Journal of Urology","volume":"66 1","pages":"101097JU0000000000004945"},"PeriodicalIF":0.0,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146015119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-21DOI: 10.1097/ju.0000000000004943
J Quentin Clemens,Bruce D Naliboff,Catherine S Bradley,Claire C Yang,Daniel J Clauw,David Williams,H Henry Lai,Siobhan Sutcliffe,Steven E Harte,Theresa Spitznagle,J Richard Landis
PURPOSEWe utilized prospective data from a well-characterized urologic chronic pelvic pain (UCPPS) cohort (including interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome) to identify transitions between localized pelvic pain (LP) and widespread pain (WP), and characteristics associated with these transitions.MATERIAL AND METHODSA total of 311 individuals (195 women; 116 men) with UCPPS were recruited from 6 sites and followed for 3 years. Participants completed five weekly "run-in" assessments at baseline, followed by quarterly symptom assessments. Responses on a self-reported body pain map were used to define LP vs WP (>2 non-pelvic body map regions with pain). Multivariable modeling was used to evaluate 74 baseline characteristics related to transitions between LP and WP.RESULTSAt baseline, 126 participants (41%) reported LP, 13 (10.3%) of whom transitioned to WP. Conversely, 17 of the 66 participants (26%) with WP transitioned to LP at follow-up. Progression from LP to WP was associated with: 1) not living with a partner/spouse, and 2) a higher Somatic Awareness Score on the Complex Multi-System Inventory (CMSI). Conversely, transition from WP to LP was associated with: 3) lower urinary urgency symptoms on the CMSI, and 4) higher frequency of sensation of not emptying bladder completely.CONCLUSIONSGreater levels of baseline non-painful somatic symptoms were associated with progression to widespread pain, suggesting that high baseline somatic symptoms may predict the development of future pain. Not living with a spouse/partner was also associated with progression to widespread pain, highlighting the importance of social support in UCPPS.
{"title":"Transitions from Regional to Widespread Pain in Urologic Chronic Pelvic Pain Syndrome (UCPPS): A MAPP II Research Network Study.","authors":"J Quentin Clemens,Bruce D Naliboff,Catherine S Bradley,Claire C Yang,Daniel J Clauw,David Williams,H Henry Lai,Siobhan Sutcliffe,Steven E Harte,Theresa Spitznagle,J Richard Landis","doi":"10.1097/ju.0000000000004943","DOIUrl":"https://doi.org/10.1097/ju.0000000000004943","url":null,"abstract":"PURPOSEWe utilized prospective data from a well-characterized urologic chronic pelvic pain (UCPPS) cohort (including interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome) to identify transitions between localized pelvic pain (LP) and widespread pain (WP), and characteristics associated with these transitions.MATERIAL AND METHODSA total of 311 individuals (195 women; 116 men) with UCPPS were recruited from 6 sites and followed for 3 years. Participants completed five weekly \"run-in\" assessments at baseline, followed by quarterly symptom assessments. Responses on a self-reported body pain map were used to define LP vs WP (>2 non-pelvic body map regions with pain). Multivariable modeling was used to evaluate 74 baseline characteristics related to transitions between LP and WP.RESULTSAt baseline, 126 participants (41%) reported LP, 13 (10.3%) of whom transitioned to WP. Conversely, 17 of the 66 participants (26%) with WP transitioned to LP at follow-up. Progression from LP to WP was associated with: 1) not living with a partner/spouse, and 2) a higher Somatic Awareness Score on the Complex Multi-System Inventory (CMSI). Conversely, transition from WP to LP was associated with: 3) lower urinary urgency symptoms on the CMSI, and 4) higher frequency of sensation of not emptying bladder completely.CONCLUSIONSGreater levels of baseline non-painful somatic symptoms were associated with progression to widespread pain, suggesting that high baseline somatic symptoms may predict the development of future pain. Not living with a spouse/partner was also associated with progression to widespread pain, highlighting the importance of social support in UCPPS.","PeriodicalId":501636,"journal":{"name":"The Journal of Urology","volume":"30 1","pages":"101097JU0000000000004943"},"PeriodicalIF":0.0,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146015121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-21DOI: 10.1097/ju.0000000000004944
Parviz K Kavoussi,Jason Weiss,Jeissen Pyo,Romtin Mehrabani-Farsi,Laurel Foster,Arya Farahi,Negar Farzaneh,Lauren E Myers,Robert B Sloan,Parker R Brown,Shahryar K Kavoussi
PURPOSETo assess varicocele repair effect on semen parameters and improved candidacy for in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) or lesser involved treatment options depending on semen parameter response following varicocele repair in infertile men presenting with baseline semen analyses revealing cryptozoospermia.MATERIALS AND METHODSA retrospective chart review of the electronic health records was performed in men presenting for fertility evaluation with a palpable varicocele on physical examination and at least 2 consecutive semen analyses revealing cryptozoospermia who underwent subinguinal microsurgical varicocele repair.RESULTSOf the 24 men with cryptozoospermia who underwent varicocele repair, 54% had improvement in semen parameters from cryptozoospermia preoperatively to semen parameters ranging from severely oligozoospermic to normozoospermic 3 to 6 months postoperatively. Statistical analyses did not demonstrate significant associations between patient age, follicle-stimulating hormone (FSH) level, or clinical grade of varicocele and semen parameter response following varicocele repair.CONCLUSIONSGreater than half of the men with cryptozoospermia that underwent varicocele repair improved semen parameters to be optimized for IVF/ICSI or potentially lesser involved fertility treatments and obviated the need for surgical sperm retrieval. Neither patient age, serum FSH level, nor clinical grade of varicocele showed a statistically significant association with favorable versus unfavorable semen parameter response to varicocele repair in infertile men with preoperative cryptozoospermia.This data suggests varicocele repair may be offered to infertile, cryptozoospermic men with palpable varicoceles.
{"title":"Semen parameter response to varicocele repair in infertile men with cryptozoospermia.","authors":"Parviz K Kavoussi,Jason Weiss,Jeissen Pyo,Romtin Mehrabani-Farsi,Laurel Foster,Arya Farahi,Negar Farzaneh,Lauren E Myers,Robert B Sloan,Parker R Brown,Shahryar K Kavoussi","doi":"10.1097/ju.0000000000004944","DOIUrl":"https://doi.org/10.1097/ju.0000000000004944","url":null,"abstract":"PURPOSETo assess varicocele repair effect on semen parameters and improved candidacy for in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) or lesser involved treatment options depending on semen parameter response following varicocele repair in infertile men presenting with baseline semen analyses revealing cryptozoospermia.MATERIALS AND METHODSA retrospective chart review of the electronic health records was performed in men presenting for fertility evaluation with a palpable varicocele on physical examination and at least 2 consecutive semen analyses revealing cryptozoospermia who underwent subinguinal microsurgical varicocele repair.RESULTSOf the 24 men with cryptozoospermia who underwent varicocele repair, 54% had improvement in semen parameters from cryptozoospermia preoperatively to semen parameters ranging from severely oligozoospermic to normozoospermic 3 to 6 months postoperatively. Statistical analyses did not demonstrate significant associations between patient age, follicle-stimulating hormone (FSH) level, or clinical grade of varicocele and semen parameter response following varicocele repair.CONCLUSIONSGreater than half of the men with cryptozoospermia that underwent varicocele repair improved semen parameters to be optimized for IVF/ICSI or potentially lesser involved fertility treatments and obviated the need for surgical sperm retrieval. Neither patient age, serum FSH level, nor clinical grade of varicocele showed a statistically significant association with favorable versus unfavorable semen parameter response to varicocele repair in infertile men with preoperative cryptozoospermia.This data suggests varicocele repair may be offered to infertile, cryptozoospermic men with palpable varicoceles.","PeriodicalId":501636,"journal":{"name":"The Journal of Urology","volume":"101 1","pages":"101097JU0000000000004944"},"PeriodicalIF":0.0,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146015420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-20DOI: 10.1097/ju.0000000000004929
D Robert Siemens
{"title":"Is This the End of the \"Letter to the Editor\"?","authors":"D Robert Siemens","doi":"10.1097/ju.0000000000004929","DOIUrl":"https://doi.org/10.1097/ju.0000000000004929","url":null,"abstract":"","PeriodicalId":501636,"journal":{"name":"The Journal of Urology","volume":"57 1","pages":"101097JU0000000000004929"},"PeriodicalIF":0.0,"publicationDate":"2026-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146005328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-20DOI: 10.1097/ju.0000000000004937
Peter N Schlegel,Sarah C Vij,Christopher Filson,Alfredo Penzo-Mendez,Akanksha Mehta
{"title":"Vasectomy and the Risk of Prostate Cancer.","authors":"Peter N Schlegel,Sarah C Vij,Christopher Filson,Alfredo Penzo-Mendez,Akanksha Mehta","doi":"10.1097/ju.0000000000004937","DOIUrl":"https://doi.org/10.1097/ju.0000000000004937","url":null,"abstract":"","PeriodicalId":501636,"journal":{"name":"The Journal of Urology","volume":"100 1","pages":"101097JU0000000000004937"},"PeriodicalIF":0.0,"publicationDate":"2026-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146005329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-16DOI: 10.1097/ju.0000000000004921
Ian M Thompson
{"title":"How \"Floor Bias\" in Gleason Grading Affects Prostate Cancer Management.","authors":"Ian M Thompson","doi":"10.1097/ju.0000000000004921","DOIUrl":"https://doi.org/10.1097/ju.0000000000004921","url":null,"abstract":"","PeriodicalId":501636,"journal":{"name":"The Journal of Urology","volume":"69 1","pages":"101097JU0000000000004921"},"PeriodicalIF":0.0,"publicationDate":"2026-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145986572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-15DOI: 10.1097/ju.0000000000004924
Giulia M Ippolito,Irene Crescenze,Phillipp Dahm,Priyanka Gupta
{"title":"Reply: Concerns Regarding the Recent Cochrane Review on Vaginal Lasers for Treating Stress Urinary Incontinence in Women.","authors":"Giulia M Ippolito,Irene Crescenze,Phillipp Dahm,Priyanka Gupta","doi":"10.1097/ju.0000000000004924","DOIUrl":"https://doi.org/10.1097/ju.0000000000004924","url":null,"abstract":"","PeriodicalId":501636,"journal":{"name":"The Journal of Urology","volume":"1 1","pages":"101097JU0000000000004924"},"PeriodicalIF":0.0,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145971830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：